FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

GAO Sees Actions, Challenges in Device Surveillance

The Government Accountability Office says FDA has faced challenges in its preparations for beginning active postmarket surveillance of medical devices...

latest-news-card-1
Human Drugs

Reps Seek FDA Action on Drug Research in China

Four House Democrats and Republicans urge FDA to take a greater role in protecting U.S. national security interests that could be at risk when drug co...

latest-news-card-1
Human Drugs

Significant CGMP Violations at Eugia Pharma

FDA warns Indias Eugia Pharma Specialties about CGMP violations in its production of finished drugs.

latest-news-card-1
Medical Devices

LDT Power Grab Suit Filed Against FDA

The Association for Molecular Pathology and a pathologist sue FDA to block implementation of the agencys final rule asserting regulatory authority ove...

latest-news-card-1
Human Drugs

Lillys Tirzepatide Curbs Progression to Diabetes

Eli Lilly says data from its SURMOUNT-1 study showed that tirzepatide contributed to significant weight loss and delayed in progression to diabetes in...

latest-news-card-1
Human Drugs

Post Timely De Novo Summaries: Law Firm

A Hyman, Phelps & McNamara medical device regulatory expert and attorney say FDA needs to improve the timeliness of its posting of de novo decision su...

latest-news-card-1
Medical Devices

ICU Medical Expands Class 1 Recall of Infusion Pumps

ICU Medical expands a Class 1 recall of its Plum 360, Plum A+ and Plum A+3 Infusion Systems to update the use instructions due to a manufacturing defe...

latest-news-card-1
Human Drugs

Transplant Drug Gets Orphan/Fast Track Status

FDA grants ReAlta Life Sciences orphan drug and fast track designations for RLS-0071 and its use in treating hospitalized patients with steroid-refrac...

latest-news-card-1
Federal Register

Pennsaid Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that Horizon Therapeutics Pennsaid (diclofenac sodium) topical solution 2% was not withdrawn due to safety or ...

latest-news-card-1
Federal Register

ANDA Product-Specific Meeting Request Guide

Federal Register notice: FDA makes available a final guidance entitled Product-Specific Guidance Meetings Between FDA and ANDA Applicants Under GDUFA....